Sclerosis multiplex (SM): vizsgálatok itt: India

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Chandigarh, Gurugram, Hyderabad, Kochi, Mangalore, New Delhi, Vellore

  Életkor

  18 év to 65 év

  People

  1275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504